Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Expert Review of Anti-Infective Therapy
|
May 5, 2025
Letter to the editor regarding "Alternative drugs for the treatment of gonococcal infections: old and new" <i>Expert Review of Anti-infective Therapy</i>. 2024. 22(9):753-759
Alison Luckey, David Altarac, Sarah M McLeod
Neuroimage
|
December 19, 2021
Predisposition to domain-wide maladaptive changes in predictive coding in auditory phantom perception
Anusha Mohan, Alison Luckey, Nathan Weisz, et al.
Lancet (London, England)
|
May 10, 2026
Zoliflodacin: non-inferior, but not equivalent? - Authors' reply
Alison Luckey, Manica Balasegaram, Drew Lewis, et al.
The European Journal of Neuroscience
|
March 19, 2021
Impaired posterior cingulate cortex-parahippocampus connectivity is associated with episodic memory retrieval problems in amnestic mild cognitive impairment
Sven Vanneste, Alison Luckey, S Lauren McLeod, et al.
Clinical and Translational Science
|
February 24, 2023
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
Alison Luckey, Emilie Alirol, Sophie Delhomme, et al.
European Journal of Clinical Pharmacology
|
January 22, 2024
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation
Shampa Das, Todd Riccobene, Timothy J Carrothers, et al.
Clinical and Translational Science
|
February 27, 2026
Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants
Alison Luckey, Kajal B Larson, Noha Rayad, et al.
The Lancet. Microbe
|
February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study
Magnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
BMC Global and Public Health
|
December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin
Fernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
The Journal of Antimicrobial Chemotherapy
|
December 13, 2019
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
Oliver A Cornely, José M Cisneros, Julian Torre-Cisneros, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Expert Review of Anti-Infective Therapy
|
May 5, 2025
Letter to the editor regarding "Alternative drugs for the treatment of gonococcal infections: old and new" <i>Expert Review of Anti-infective Therapy</i>. 2024. 22(9):753-759
Alison Luckey, David Altarac, Sarah M McLeod
Neuroimage
|
December 19, 2021
Predisposition to domain-wide maladaptive changes in predictive coding in auditory phantom perception
Anusha Mohan, Alison Luckey, Nathan Weisz, et al.
Lancet (London, England)
|
May 10, 2026
Zoliflodacin: non-inferior, but not equivalent? - Authors' reply
Alison Luckey, Manica Balasegaram, Drew Lewis, et al.
The European Journal of Neuroscience
|
March 19, 2021
Impaired posterior cingulate cortex-parahippocampus connectivity is associated with episodic memory retrieval problems in amnestic mild cognitive impairment
Sven Vanneste, Alison Luckey, S Lauren McLeod, et al.
Clinical and Translational Science
|
February 24, 2023
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects
Alison Luckey, Emilie Alirol, Sophie Delhomme, et al.
European Journal of Clinical Pharmacology
|
January 22, 2024
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation
Shampa Das, Todd Riccobene, Timothy J Carrothers, et al.
Clinical and Translational Science
|
February 27, 2026
Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants
Alison Luckey, Kajal B Larson, Noha Rayad, et al.
The Lancet. Microbe
|
February 8, 2026
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study
Magnus Unemo, Daniel Golparian, Varalakshmi Elango, et al.
BMC Global and Public Health
|
December 16, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin
Fernando Pascual, Carmen Au, Chido Dziva Chikwari, et al.
The Journal of Antimicrobial Chemotherapy
|
December 13, 2019
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study
Oliver A Cornely, José M Cisneros, Julian Torre-Cisneros, et al.
Page
of 2